|
|
|
Volumn 16, Issue 9, 1997, Pages 913-916
|
|
Induction immunotherapy in heart transplantation with T10B9.1A-31: A Phase I study
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AZATHIOPRINE;
CYCLOSPORIN;
METHYLPREDNISOLONE;
METHYLPREDNISOLONE SODIUM SUCCINATE;
MONOCLONAL ANTIBODY;
MONOCLONAL ANTIBODY T10B9;
OKT 3;
PREDNISONE;
UNCLASSIFIED DRUG;
ARTICLE;
CARDIOPULMONARY BYPASS;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFICACY;
GRAFT REJECTION;
GRAFT SURVIVAL;
HEART TRANSPLANTATION;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
INTRAVENOUS DRUG ADMINISTRATION;
PHASE 1 CLINICAL TRIAL;
PRIORITY JOURNAL;
ADULT;
ANTIBODIES, ANTI-IDIOTYPIC;
ANTIBODIES, MONOCLONAL;
BIOPSY;
CYCLOSPORINE;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
DRUG THERAPY, COMBINATION;
ENDOCARDIUM;
FEMALE;
FOLLOW-UP STUDIES;
GRAFT REJECTION;
HEART TRANSPLANTATION;
HUMANS;
IMMUNOGLOBULIN ISOTYPES;
IMMUNOSUPPRESSIVE AGENTS;
MALE;
MIDDLE AGED;
MUROMONAB-CD3;
MYOCARDIUM;
RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA;
TREATMENT OUTCOME;
|
|
EID: 0030932033
PISSN: 10532498
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (14)
|
|
References (9)
|
